Seeing Is Believing
Currently out of the existing stock ratings of Yasmeen Rahimi, 273 are a BUY (96.13%), 11 are a HOLD (3.87%).
Analyst Yasmeen Rahimi, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 33.92% that have a potential upside of 41.09% achieved within 183 days.
Yasmeen Rahimi’s has documented 554 price targets and ratings displayed on 52 stocks. The coverage is on Healthcare, Industrials, Technology sectors.
Most recent stock forecast was given on PRTA, Prothena plc at 26-May-2025.
Analyst best performing recommendations are on NRBO (NEUROBO PHARMACEUTICALS).
The best stock recommendation documented was for NRBO (NEUROBO PHARMACEUTICALS) at 8/9/2018. The price target of $12000 was fulfilled within 1 day with a profit of $7620 (38.84%) receiving and performance score of 388.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$42
$-2.15 (-4.87%)
$42
2 years 8 months 1 days ago
(14-Feb-2023)
0/15 (0%)
$-2.18 (-4.93%)
Buy
$42
$-2.15 (-4.87%)
$82
2 years 9 months 5 days ago
(10-Jan-2023)
0/4 (0%)
$-2.1 (-4.76%)
Buy
$42
$-2.15 (-4.87%)
$68
2 years 9 months 5 days ago
(10-Jan-2023)
0/3 (0%)
$-2.1 (-4.76%)
Hold
$55
2 years 9 months 5 days ago
(10-Jan-2023)
0/1 (0%)
$36.77 (201.70%)
Hold
$42
$-2.15 (-4.87%)
$61
2 years 9 months 7 days ago
(08-Jan-2023)
0/2 (0%)
$-1.85 (-4.22%)
Which stock is Yasmeen Rahimi is most bullish on?
Which stock is Yasmeen Rahimi is most reserved on?
What Year was the first public recommendation made by Yasmeen Rahimi?